ATE236257T1 - Enzymatisches verfahren dass enzyme die an der zellwand einer eukaryontischen mikrobiellen zelle durch schaffung eines fusionsproteins immobilisiert wurden verwendet. - Google Patents

Enzymatisches verfahren dass enzyme die an der zellwand einer eukaryontischen mikrobiellen zelle durch schaffung eines fusionsproteins immobilisiert wurden verwendet.

Info

Publication number
ATE236257T1
ATE236257T1 AT93915827T AT93915827T ATE236257T1 AT E236257 T1 ATE236257 T1 AT E236257T1 AT 93915827 T AT93915827 T AT 93915827T AT 93915827 T AT93915827 T AT 93915827T AT E236257 T1 ATE236257 T1 AT E236257T1
Authority
AT
Austria
Prior art keywords
cell wall
pct
enzyme
cell
protein
Prior art date
Application number
AT93915827T
Other languages
English (en)
Inventor
Franciscus Maria Klis
Maarten Pleun Schreuder
Holger York Toschka
Cornelis Theodorus Verrips
Original Assignee
Unilever Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unilever Nv filed Critical Unilever Nv
Application granted granted Critical
Publication of ATE236257T1 publication Critical patent/ATE236257T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2465—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1) acting on alpha-galactose-glycoside bonds, e.g. alpha-galactosidase (3.2.1.22)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • C07K14/39—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
    • C07K14/395—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts from Saccharomyces
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/16—Enzymes or microbial cells immobilised on or in a biological cell
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0006—Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • C12N9/20—Triglyceride splitting, e.g. by means of lipase
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/035—Fusion polypeptide containing a localisation/targetting motif containing a signal for targeting to the external surface of a cell, e.g. to the outer membrane of Gram negative bacteria, GPI- anchored eukaryote proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT93915827T 1992-07-08 1993-07-07 Enzymatisches verfahren dass enzyme die an der zellwand einer eukaryontischen mikrobiellen zelle durch schaffung eines fusionsproteins immobilisiert wurden verwendet. ATE236257T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP92202080 1992-07-08
EP92203899 1992-12-14
PCT/EP1993/001763 WO1994001567A1 (en) 1992-07-08 1993-07-07 Process for immobilizing enzymes to the cell wall of a microbial cell by producing a fusion protein

Publications (1)

Publication Number Publication Date
ATE236257T1 true ATE236257T1 (de) 2003-04-15

Family

ID=26131543

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93915827T ATE236257T1 (de) 1992-07-08 1993-07-07 Enzymatisches verfahren dass enzyme die an der zellwand einer eukaryontischen mikrobiellen zelle durch schaffung eines fusionsproteins immobilisiert wurden verwendet.

Country Status (16)

Country Link
US (1) US6027910A (de)
EP (1) EP0673427B1 (de)
JP (2) JP3681385B2 (de)
KR (1) KR950702634A (de)
AT (1) ATE236257T1 (de)
AU (1) AU685057B2 (de)
CA (1) CA2139670C (de)
DE (1) DE69332829T2 (de)
DK (1) DK0673427T3 (de)
ES (1) ES2196009T3 (de)
FI (1) FI950042A7 (de)
NZ (1) NZ254108A (de)
OA (1) OA10123A (de)
PT (1) PT673427E (de)
RU (1) RU95105899A (de)
WO (1) WO1994001567A1 (de)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030036092A1 (en) * 1991-11-15 2003-02-20 Board Of Regents, The University Of Texas System Directed evolution of enzymes and antibodies
US5866344A (en) * 1991-11-15 1999-02-02 Board Of Regents, The University Of Texas System Antibody selection methods using cell surface expressed libraries
AU6139794A (en) * 1993-02-10 1994-08-29 Unilever Plc Immobilized proteins with specific binding capacities and their use in processes and products
CA2134354A1 (en) * 1993-02-26 1994-09-01 Junji Watari Yeast agglutination genes and yeast containing them
GB9423367D0 (en) * 1994-11-18 1995-01-11 Wellcome Found Enzyme prodrug therapy
US6696251B1 (en) 1996-05-31 2004-02-24 Board Of Trustees Of The University Of Illinois Yeast cell surface display of proteins and uses thereof
US6300065B1 (en) 1996-05-31 2001-10-09 Board Of Trustees Of The University Of Illinois Yeast cell surface display of proteins and uses thereof
US6699658B1 (en) 1996-05-31 2004-03-02 Board Of Trustees Of The University Of Illinois Yeast cell surface display of proteins and uses thereof
US6759243B2 (en) 1998-01-20 2004-07-06 Board Of Trustees Of The University Of Illinois High affinity TCR proteins and methods
US7390619B1 (en) 1998-02-11 2008-06-24 Maxygen, Inc. Optimization of immunomodulatory properties of genetic vaccines
IL145337A0 (en) 1999-03-25 2002-06-30 Valtion Teknillinen Process for partitioning of proteins
JP2003284556A (ja) * 1999-11-19 2003-10-07 Toyota Motor Corp 金属捕捉能タンパク質を発現する遺伝子
EP1134231B1 (de) 2000-03-14 2009-04-15 Unilever N.V. Variabele Domänen der schweren Kette eines Antikörpers gegen menschliche Ernährungslipasen und deren Verwendungen
DE10016279A1 (de) * 2000-04-03 2001-10-04 Henkel Kgaa Enzymatisches Färbemittel
ATE403717T1 (de) * 2000-05-01 2008-08-15 Daiichi Sankyo Co Ltd Verfahren zum screening von auf zellwände wirkenden arzneistoffen
US7063738B2 (en) * 2000-05-15 2006-06-20 Schlumberger Technology Corporation Permeable cements
NZ541266A (en) 2000-07-07 2006-11-30 Eisai Co Ltd DNA encoding proteins participating in fungal cell wall synthesis
WO2002046400A2 (en) * 2000-12-08 2002-06-13 The Board Of Trustees Of The University Of Illinois Mutated class ii major histocompatibility proteins
US7192764B2 (en) * 2001-04-19 2007-03-20 Kansai Chemical Engineering, Co. Cell surface layer-binding protein and utilization thereof
DK1395648T3 (da) 2001-06-11 2009-08-03 Applied Nanosystems Bv Fremgangsmåder til binding af AcmA-type proteinankerfusioner til cellevægsmateriale af mikroorganismer
WO2003029456A1 (en) 2001-10-01 2003-04-10 Dyax Corp. Multi-chain eukaryotic display vectors and uses thereof
ES2294172T3 (es) 2001-10-22 2008-04-01 Daiichi Sankyo Company, Limited Procedimiento para cribar un medicamento que actua sobre la pared celular.
US20040067532A1 (en) 2002-08-12 2004-04-08 Genetastix Corporation High throughput generation and affinity maturation of humanized antibody
US7563600B2 (en) 2002-09-12 2009-07-21 Combimatrix Corporation Microarray synthesis and assembly of gene-length polynucleotides
EP2497478A3 (de) 2003-12-05 2012-11-07 Children's Hospital Medical Center Oligosaccarid-Zusammensetzungen und ihre Verwendung bei der Behandlung von Infektionen
WO2007005612A2 (en) * 2005-07-01 2007-01-11 Medimmune, Inc. An integrated approach for generating multidomain protein therapeutics
WO2007009082A1 (en) * 2005-07-12 2007-01-18 Codon Devices, Inc. Compositions and methods for biocatalytic engineering
EP1943332A4 (de) * 2005-10-14 2011-04-13 Medimmune Inc Zellpräsentation von antikörperbibliotheken
US20070231805A1 (en) * 2006-03-31 2007-10-04 Baynes Brian M Nucleic acid assembly optimization using clamped mismatch binding proteins
US20080138663A1 (en) * 2006-12-12 2008-06-12 Canon Kabushiki Kaisha Microbial electrode and fuel cell and sensor using the same
US20110076752A1 (en) * 2007-02-09 2011-03-31 Medimmune, Llc Antibody library display by yeast cell plasma membrane
US8709980B2 (en) * 2007-03-26 2014-04-29 Celexion, Llc Cell surface display, screening and production of proteins of interest
US12529164B2 (en) 2007-09-14 2026-01-20 Adimab, Llc Rationally designed, synthetic antibody libraries and uses therefor
US8877688B2 (en) 2007-09-14 2014-11-04 Adimab, Llc Rationally designed, synthetic antibody libraries and uses therefor
EP3124497B1 (de) 2007-09-14 2020-04-15 Adimab, LLC Synthetische antikörperbibliotheken mit rationalem design und verwendungen davon
CN102245771B (zh) 2008-12-16 2013-04-10 诺瓦提斯公司 酵母展示系统
KR102024922B1 (ko) 2010-07-16 2019-09-25 아디맵 엘엘씨 항체 라이브러리
US8765425B2 (en) 2011-03-23 2014-07-01 Butamax Advanced Biofuels Llc In situ expression of lipase for enzymatic production of alcohol esters during fermentation
US8759044B2 (en) 2011-03-23 2014-06-24 Butamax Advanced Biofuels Llc In situ expression of lipase for enzymatic production of alcohol esters during fermentation
EP4284905A1 (de) 2021-01-28 2023-12-06 Novozymes A/S Lipase mit geringer geruchsbildung
KR20250005200A (ko) 2022-04-20 2025-01-09 노보자임스 에이/에스 유리 지방산을 제조하는 방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU626288B2 (en) * 1988-02-05 1992-07-30 Commonwealth Scientific And Industrial Research Organisation Gene expression system (particularly for rotavirus vp7 protein) involving a foreign signal peptide and optionally a transmembrane anchor sequence
SG70982A1 (en) * 1990-01-23 2000-03-21 Tanox Biosystems Inc Extracellular segments of human and immunoglobulin anchoring peptides and antibodies specific therefor
US5348867A (en) * 1991-11-15 1994-09-20 George Georgiou Expression of proteins on bacterial surface

Also Published As

Publication number Publication date
PT673427E (pt) 2003-08-29
FI950042L (fi) 1995-01-24
EP0673427B1 (de) 2003-04-02
ES2196009T3 (es) 2003-12-16
AU685057B2 (en) 1998-01-15
NZ254108A (en) 1995-12-21
CA2139670C (en) 2005-09-27
DE69332829T2 (de) 2004-01-22
KR950702634A (ko) 1995-07-29
AU4565393A (en) 1994-01-31
WO1994001567A1 (en) 1994-01-20
CA2139670A1 (en) 1994-01-20
JP2004254700A (ja) 2004-09-16
FI950042A7 (fi) 1995-01-24
JPH07508652A (ja) 1995-09-28
JP3681385B2 (ja) 2005-08-10
OA10123A (en) 1996-12-18
FI950042A0 (fi) 1995-01-04
RU95105899A (ru) 1997-03-20
EP0673427A1 (de) 1995-09-27
US6027910A (en) 2000-02-22
DK0673427T3 (da) 2003-07-21
DE69332829D1 (de) 2003-05-08

Similar Documents

Publication Publication Date Title
DE69332829D1 (de) Enzymatisches verfahren dass enzyme die an der zellwand einer eukaryontischen mikrobiellen zelle durch schaffung eines fusionsproteins immobilisiert wurden verwendet.
AU691374B2 (en) 5' to 3' exonuclease mutations of thermostable DNA polymerases
JPH1189588A5 (de)
Brown et al. Structural modifications associated with the change in Ca2+ sensitivity on activation of m‐calpain
CA2240570A1 (en) Mutant chimeric dna polymerase
FI953792A0 (fi) Immobilisoidut proteiinit, joilla on spesifiset sitoutumiskyvyt, ja niiden käyttö menetelmissä ja tuotteissa
DK0771870T3 (da) Reversibel inaktivering af termostabile enzymer under anvendelse af dicarboxylsyreanhydrid og anvendelse i amplificeringsfr
ES2077220T3 (es) Hidrolizados de proteinas.
DE69226636D1 (de) Stabilisierte enzyme
NO20005428L (no) Varmelabil uracil-DNA-glykosylase, samt anvendelse derav
HRP960078B1 (en) Dna sequence coding for a protein of a. thaliana having a delta-5, 7 sterol, delta- 7 reductase activity, delta-7-red protein, production process, strains of transformed yeasts, uses
DK0418945T3 (da) Forgreningsenzym og dets anvendelse
ATE366120T1 (de) Hocheffizientes gewebespezifisches system zur bereitstellung von verbindungen unter verwendung eines streptavidin-protein a fusionsproteins
SE8603037L (sv) Stabiliserad forsterkt flytande detergentkomposition innehallande enzymer
JPS60500043A (ja) 原核細胞又は真核細胞中で合成される融合蛋白質から成熟蛋白質を作る方法
EP1293571A3 (de) Verfahren zur Immobilisierung von Enzymen an der Zellwand einer eukaryotischen mikrobiellen Zelle durch Schaffung eines Fusionsproteins
Nakagawa et al. Enzymatic cleavage of amino terminal methionine from recombinant human interleukin 2 and growth hormone by aminopeptidase M
Sakai et al. A new carboxylesterase from Brevibacterium linens IFO 12171 responsible for the conversion of 1, 4-butanediol diacrylate to 4-hydroxybutyl acrylate: purification, characterization, gene cloning, and gene expression in Escherichia coli
MXPA03001333A (es) Butinol i esterasa.
KR100320038B1 (ko) 로도코커스 로도크로스(Ｒｈｏｄｏｃｏｃｃｕｓｒｈｏｄｏｃｈｒｏｕｓ) Ｍ33 ＶＫＭ Ａｃ-1515Ｄ로부터유래된 니트릴 히드라타제를 코딩하는 유전자 및 이유전자를 함유한 형질전환체
GB2297090B (en) alpha-1,4-Glucan lyase from a fungus infected algae, its purification, gene cloning and expression in microorganisms
Shao Mechanism of protein splicing
JPH09131181A (ja) 変異型ｄｎａポリメラーゼ
DK46190D0 (da) Acylpeptidhydrolyse samt fremgangsmaade til fremstilling og anvendelse deraf
OXYDA PURIFIED LUCIFERASE FROM LUCIOLA LATERALIS

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0673427

Country of ref document: EP